Hippocratic AI's $126 million Series C, announced November 3, 2025 at a $3.5 billion valuation, bought growth capital by selling roughly 3.6 percent of the company, and every existing shareholder's stake shrank by that fraction. Dilution is the mechanic every priced round uses, and the arithmetic is simple enough to check by hand.
How does selling equity shrink existing stakes?
A priced round creates new shares and sells them to investors at an agreed price per share. The percentage the new investors receive equals the money invested divided by the post-money valuation; here, $126 million over $3.5 billion is about 3.6 percent. Every founder, employee and earlier investor keeps the same number of shares but owns a smaller fraction of a larger company, a mechanic that applies identically to any priced round using the announced figures.
The announcement documents the round's structure: led by Avenir Growth with participation from CapitalG, General Catalyst, Andreessen Horowitz, Kleiner Perkins and strategic healthcare investors, bringing total funding to $404 million per the round coverage. Each of those earlier checks did the same thing this one does: converted money into ownership, one layer at a time.
When is dilution worth it?
The trade is only rational when the round grows the denominator faster than it shrinks the fraction. A founder holding 20 percent of a company worth $1 billion is better off than one holding 40 percent of a company worth $200 million, which is why investors and founders negotiate valuation so hard. The protection against unfavorable dilution lives in the term sheet: anti-dilution provisions, liquidation preferences and option-pool sizing all shift who absorbs the shrinking.
Hippocratic AI's successive rounds show the favorable case, where each round's dilution came with a step up in price per share, meaning early holders own less of the company but their slices are worth more on paper. The unfavorable case is the down round, where new money prices lower and existing stakes shrink without compensation, which is when the term-sheet details start to matter.
What should founders watch in a term sheet?
Three lines dominate the dilution math. First, the option pool: investors often require a fresh employee pool created before their money arrives, which dilutes existing holders rather than the new investor. Second, liquidation preferences determine who recovers capital first at an exit and can make headline valuations misleading. Third, anti-dilution clauses protect investors if a later round prices lower, shifting downside dilution onto common shareholders.
None of these terms appear in a funding announcement, which publishes the round size and valuation but not the preferences stacked on top of them. That is why the $3.5 billion headline is the beginning of the analysis, not the end, and why experienced founders read the full document before celebrating the number in the press release.
